Just In
A tectonic shift is underway, when it comes to women-led development. Look at the result of our competitive exams. And how women are leading the way: Amitabh Kant, Ex-G20 Sherpa, India & Ex-CEO, NITI Aayog at Fortune India's MPW 2025
Pushing for women-led development was even more difficult than the Russia-Ukraine war, and no development can ever happen if you don’t include women: Amitabh Kant, Ex-G20 Sherpa, India & Ex-CEO, NITI Aayog at Fortune India’s MPW 2025
Pushing for women-led development as part of the G20, we found opposition from many nations like Saudi Arabia and Türkiye: Amitabh Kant, Ex-G20 Sherpa, India & Ex-CEO, NITI Aayog at Fortune India MPW 2025
Of the 980 million working-age Indians, only 18% women contribute to the GDP — unless this rises to 50%, India cannot become a developed economy: Amitabh Kant, Ex-G20 Sherpa, India & Ex-CEO, NITI Aayog at Fortune India's MPW 2025
A tectonic shift is underway, when it comes to women-led development. Look at the result of our competitive exams. And how women are leading the way: Amitabh Kant, Ex-G20 Sherpa, India & Ex-CEO, NITI Aayog at Fortune India's MPW 2025
Pushing for women-led development was even more difficult than the Russia-Ukraine war, and no development can ever happen if you don’t include women: Amitabh Kant, Ex-G20 Sherpa, India & Ex-CEO, NITI Aayog at Fortune India’s MPW 2025
Pushing for women-led development as part of the G20, we found opposition from many nations like Saudi Arabia and Türkiye: Amitabh Kant, Ex-G20 Sherpa, India & Ex-CEO, NITI Aayog at Fortune India MPW 2025
Of the 980 million working-age Indians, only 18% women contribute to the GDP — unless this rises to 50%, India cannot become a developed economy: Amitabh Kant, Ex-G20 Sherpa, India & Ex-CEO, NITI Aayog at Fortune India's MPW 2025

Aurobindo Pharma USFDA approval

(1 search result)

Aurobindo Pharma shares rise 2% on USFDA nod for nasal spray